SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Analysts and calls -- US Bancorp Piper Jaffray

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Icebrg who wrote (15)7/9/2003 7:04:26 PM
From: Icebrg  Read Replies (1) of 22
 
Affymetrix initiated with "outperform" - update

Updated Tuesday, July 08, 2003 1:07:57 PM ET
US Bancorp Piper Jaffray

NEW YORK, July 8 (New Ratings) – Analyst Edward Tenthoff of US Bancorp Piper Jaffray initiates coverage of Affymetrix (AFFX) with an "outperform" rating.

In a research note published this morning, the analyst mentions that the company’s stock is stabilizing. The company’s imminent product launches are likely to enable Affymetrix to post EPS growth in H203 and 2004, adds the analyst.

The stock closed at 21.64
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext